Redeye endorses ISAB"s collaboration with a leading Indian pharmaceutical company, recognizing it as a significant stride into the Indian market and expanding ISAB’s geographic footprint in the Asian market. This partnership, driven by ISAB"s DissolvIt module, represents a strategic move to improve research precision in drug development within India"s growing pharmaceutical sector. In light of this collaboration, we reiterate our base case.

Link to the analysis